Cancer Trials Australia Email Formats

About Cancer Trials Australia

For over 20 years, Cancer Trials Australia (CTA) has played a crucial role in providing site administration and management services for clinical trials, spanning feasibility through to close-out, covering start-up regulatory submissions, budget and contract negotiations, amendments, and billing on behalf of our hospital members. Having supported the administration of 2,200+ clinical trials, sponsored by 350+ biotechnology and pharmaceutical companies, that have recruited in excess of 14,000 Australian patients, CTA is focused on its service provision to ensure that studies are managed efficiently. In addition to our clinical trial administration services, we have been involved in a number of significant sector development initiatives since our inception, including; implementing the Mutual Acceptance Program (MAP) across our Members; assisting with the development of a standard clinical trial agreement template for sponsored trials now known as the Medicines Australia Standard Clinical Trial Research Agreement template; the development of a First Time in Human (FTIH) protocol to enable Human Research Ethics Committees (HRECs) to strengthen their capacity to review Early Phase research; developing a pre-screening protocol, to allow patients to be screened at their local hospital for clinical trial participation at another hospital; convening a Phase 1 Fellowship Program to increase capacity for sites to coordinate FTIH trials; administering a range of projects aimed at increasing clinical trial education and capacity building through Victorian Comprehensive Cancer Centre initiatives and most recently the coordination of the Australian Clinical Trials Education Centre (A-CTEC) to support a dedicated Learning Management System (LMS) hosting a suite of evidence-based, interactive clinical trial education opportunities for Australian clinical trial staff.

View contact profiles from Cancer Trials Australia